Studies on the activation of the complement cascades in AMD have highlighted the role these pathways play in disease progression, and specific components of the complement pathways, including C3 and C5, have been identified in drusen from patients with AMD [51,52]. This evidence concerns the gene C5 and age-related macular degeneration.